These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 26980168)
1. Use of closed systems in the Hospital Pharmacy. Forte Pérez-Minayo M; Castillo Bazán E; Hernández Segurado M; Arias Moya MÁ; Pelegrín Torres P; Bécares Martínez FJ Farm Hosp; 2016 Mar; 40(2):102-10. PubMed ID: 26980168 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of surface contamination in a hospital hematology--oncology pharmacy. Touzin K; Bussières JF; Langlois E; Lefebvre M J Oncol Pharm Pract; 2009 Mar; 15(1):53-61. PubMed ID: 18772214 [TBL] [Abstract][Full Text] [Related]
3. Impact of the new handling recommendations for hazardous drugs in a hospital pharmacy service. García-Alcántara BG; Perelló Alomar C; Moreno Centeno E; Modamio P; Mariño EL; Delgado Sánchez O Farm Hosp; 2017 Mar; 41(2):257-269. PubMed ID: 28236800 [TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness study of closed system transfer devices for the preparation of antineoplastic agents. Calzado-Gómez G; Nazco-Casariego GJ; Viña-Romero MM; Gutiérrez-Nicolás F Farm Hosp; 2017 Sep; 41(5):575-582. PubMed ID: 28847246 [TBL] [Abstract][Full Text] [Related]
5. Impact and appreciation of two methods aiming at reducing hazardous drug environmental contamination: The centralization of the priming of IV tubing in the pharmacy and use of a closed-system transfer device. Guillemette A; Langlois H; Voisine M; Merger D; Therrien R; Mercier G; Lebel D; Bussières JF J Oncol Pharm Pract; 2014 Dec; 20(6):426-32. PubMed ID: 24395542 [TBL] [Abstract][Full Text] [Related]
6. Environmental contamination, product contamination and workers exposure using a robotic system for antineoplastic drug preparation. Sessink PJ; Leclercq GM; Wouters DM; Halbardier L; Hammad C; Kassoul N J Oncol Pharm Pract; 2015 Apr; 21(2):118-27. PubMed ID: 24567041 [TBL] [Abstract][Full Text] [Related]
7. [Evaluation of two closed-system drug transfer device in the antineoplastic drug elaboration process]. Gómez-Álvarez S; Porta-Oltra B; Hernandez-Griso M; Pérez-Labaña F; Climente-Martí M Farm Hosp; 2016 Jan; 40(1):36-43. PubMed ID: 26882832 [TBL] [Abstract][Full Text] [Related]
8. Reducing workplace cytotoxic surface contamination using a closed-system drug transfer device. Siderov J; Kirsa S; McLauchlan R J Oncol Pharm Pract; 2010 Mar; 16(1):19-25. PubMed ID: 19965949 [TBL] [Abstract][Full Text] [Related]
9. A centralized Pharmacy Unit for cytotoxic drugs in accordance with Italian legislation. Baldo P; Bertola A; Basaglia G; Moneghini M; Sorio R; Zibardi E; Lazzarini R; De Paoli P J Eval Clin Pract; 2007 Apr; 13(2):265-71. PubMed ID: 17378874 [TBL] [Abstract][Full Text] [Related]
10. The handling of antineoplastic drugs in a major cancer center. Hoffman DM Hosp Pharm; 1980 Jun; 15(6):302-4. PubMed ID: 10247269 [TBL] [Abstract][Full Text] [Related]
11. Cost savings realized by use of the PhaSeal(®) closed-system transfer device for preparation of antineoplastic agents. Edwards MS; Solimando DA; Grollman FR; Pang JL; Chasick AH; Hightman CM; Johnson AD; Mickens MG; Preston LM J Oncol Pharm Pract; 2013 Dec; 19(4):338-47. PubMed ID: 23975556 [TBL] [Abstract][Full Text] [Related]
12. Evidence of exposure to cytostatic drugs in healthcare staff: a review of recent literature. Martín Lancharro P; De Castro-Acuña Iglesias N; González-Barcala FJ; Moure González JD Farm Hosp; 2016 Nov; 40(n06):604-621. PubMed ID: 27894231 [TBL] [Abstract][Full Text] [Related]
13. Risks to health professionals from hazardous drugs in Japan: a pilot study of environmental and biological monitoring of occupational exposure to cyclophosphamide. Sugiura S; Asano M; Kinoshita K; Tanimura M; Nabeshima T J Oncol Pharm Pract; 2011 Mar; 17(1):14-9. PubMed ID: 20179165 [TBL] [Abstract][Full Text] [Related]
14. Cytotoxic drug contamination on the outside of vials delivered to a hospital pharmacy. Mason HJ; Morton J; Garfitt SJ; Iqbal S; Jones K Ann Occup Hyg; 2003 Nov; 47(8):681-5. PubMed ID: 14602675 [TBL] [Abstract][Full Text] [Related]
15. Exposure to antineoplastic drugs in two UK hospital pharmacy units. Mason HJ; Blair S; Sams C; Jones K; Garfitt SJ; Cuschieri MJ; Baxter PJ Ann Occup Hyg; 2005 Oct; 49(7):603-10. PubMed ID: 15964878 [TBL] [Abstract][Full Text] [Related]
16. Use of a closed system device to reduce occupational contamination and exposure to antineoplastic drugs in the hospital work environment. Yoshida J; Tei G; Mochizuki C; Masu Y; Koda S; Kumagai S Ann Occup Hyg; 2009 Mar; 53(2):153-60. PubMed ID: 19261696 [TBL] [Abstract][Full Text] [Related]
17. A comparative study of contamination in three closed systems for the preparation of hazardous drugs through simulations with fluorescein. González-Haba-Peña E; Manrique-Rodríguez S; Herranz-Alonso AM; Iglesias-Peinado I; Sanjurjo-Sáez M Farm Hosp; 2018 Nov; 42(6):234-238. PubMed ID: 30381043 [TBL] [Abstract][Full Text] [Related]
18. Environmental and biological monitoring of platinum-containing drugs in two hospital pharmacies using positive air pressure isolators. Kopp B; Crauste-Manciet S; Guibert A; Mourier W; Guerrault-Moro MN; Ferrari S; Jomier JY; Brossard D; Schierl R Ann Occup Hyg; 2013 Apr; 57(3):374-83. PubMed ID: 23091112 [TBL] [Abstract][Full Text] [Related]
19. Review of evidence on handling hazardous drugs and Products in Urology Services; consensus document between the Spanish Urology Association and the Spanish Society of Health-System Pharmacists. Unda-Urzáiz M; Alonso-Herreros JM; Fernández-Gómez JM; Gaspar-Carreño M; Cozar-Olmos JM; Cercós Lleti AC Farm Hosp; 2018 Sep; 42(5):212-215. PubMed ID: 30173640 [TBL] [Abstract][Full Text] [Related]
20. The PhaSeal® system: impact of its use on workplace contamination and duration of chemotherapy preparation. Favier B; Labrosse H; Gilles-Afchain L; Cropet C; Perol D; Chaumard N; Latour JF; Hild P J Oncol Pharm Pract; 2012 Mar; 18(1):37-45. PubMed ID: 21422148 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]